AbbVie Inc (NYSE: ABBV) has reported earnings for its third fiscal quarter (ending September 30) of $0.88 versus $1.00 for the same period a year ago — a decline of -12%. For the latest four quarters through September 30, E.P.S. were $2.87 versus $3.66 for the same period a year ago — a decline of -22%.
Recent Price Action
AbbVie Inc (NYSE: ABBV) stock enjoyed a very large increase of 6.4% on 10/30/24. The shares closed at $201.50. Moreover, trading volume in this advance was exceptionally high at 221% of normal. The stock has risen 6.7% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, ABBV is expected to continue to be a major Value Builder.
AbbVie has a current Value Trend Rating of C (Neutral). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. AbbVie has a neutral Appreciation Score of 49 and a slightly positive Power Rating of 64, and the Neutral Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment